Novartis AG (NYSE: NVS) Stock Coverage Initiated at Chardan Capital

Analysts at Chardan Capital initiated coverage on Novartis AG (NYSE: NVS) stock, rating the company at Buy.With a rating of Buy on the stock, the company has a 52-week high of $95.11. The one-year price target of $94.00 is above the opening price of $81.20, that has caused a fair amount of other analysts to comment on the stock recently. Price changes targets are not uncommon as analysts and brokerage firms will publish periodic updates after initiating coverage,.

U.S. stocks on Monday closed mostly flat, after trading firmly higher, in a volatile session ahead of the start of a pair of closely watched central-bank policy meetings.

The Dow Jones Industrial Average DJIA, -0.02% closed down 3.63 points at 18,120.17.

The blue-chip gauge had been up by as much as 131 points earlier and traded within a 162-point range.

The S&P 500 SPX, +0.00% slipped 0.04 points to close at 2,139.12, after trading within an 18-point range

Meanwhile, the Nasdaq Composite Index COMP, -0.18% declined 9.54 points, or 0.2%, to close at 5,235.03.

Earlier, the Nasdaq Composite Index had been up by as many as 37 points and traded with a 58-point range

Yesterday Novartis AG (NYSE: NVS) shares last traded at $81.20, which is a jump of $1.26 from the previous closing price. Opening at $81.20, they varied from $81.12 and $81.37 throughout the day.

Novartis AG (NYSE: NVS) currently has a market cap of 193.36B.

The stock’s average daily volume is 1,420,880 shares out of a total float 2,238,395,000 and some 394,114 shares crossed the trading desk yesterday, 22 percent below the norm. Swing traders often use upticks in trading volume to determine substantial volume aggregation or distribution by institutional investors, so look for trading volume to pick up in the coming days.

However, a single day of significant buy side trading is not enough to determine a trend. As such, market traders will continue to look for institutional sponsorship as a cue that financial institutions are moving forward.

Institutional sponsorship is defined by ownership of a stock by mutual funds, banks, pension funds and other large institutions.

These instituitional investors retain substantial teams of analysts that research thousands of stocks, so it is good confirmation to see them buying a stock you’re considering.

By spotting trends, moving averages allow investors to make those trends work in their favor and increase the number of successful trades.

With that in mind, Novartis AG (NYSE: NVS) now has a 50-day MA of $80.86 and 200-day MA of $78.27. It has traded in a 52-week range between $69.90 – 95.11 and today’s last price is 0.15% lower than the 52 week high of $95.11.

Indeed, earnings growth is among the most critical things to look at in regards to stock investing and, accordingly, investors identify companies that have grown their earnings at least 25% or more over 3 consecutive years.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of the website. Readers should not consider statements made by the author as formal recommendations and should consult their financial adviser before making any investment decisions. To read our full disclosure, please see our terms and conditions page.

Add a Comment

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.